Southborough, MA, United States of America

Arthur G Taveras

This inventor holds 72 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 15 EPO patents, primarily in S1P Modulating Agents (CPC class A61K). Top assignees: Schering Corporation, Biogen Ma Inc., Pharmacopeia Drug Discovery, Inc.. Active years: 1997-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur G Taveras. Retrieved from https://idiyas.com/inventor/arthur-g-taveras

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 72 (Patent Applications = 4)

% Patents Active = 70.8

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 5)

Average Co-Inventor Count = 6.1

ph-index = 15

Forward Citations = 620(Granted Patents)

Forward Citations (Not Self Cited) = 539(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Rockaway, NJ (US) (1997 - 2003)
Denville, NJ (US) (2000 - 2011)
Southborough, MA (US) (2008 - 2014)
Cambridge, MA (US) (2017)
Boston, MA (US) (2015 - 2019)

Company Filing History:

Pharmacopeia Drug Discovery, Inc.

Alantos Pharmaceuticals Holding, Inc.

Alantos Pharmaceutical Holdings, Inc.

patent

9. 1 out of 1

Atlantos Pharmaceuticals Holding, Inc.

Schering-Plough Corporation

patents

where one patent can have more than one assignee

Years Active: 1997-2019

Loading Chart...

Areas of Expertise:

Sphingosine Analog

ATX Modulators

Chemokine Inhibitors

Farnesyl Transferase

Metalloprotease Inhibitors

Cyclobutene Diones

Dipeptidyl Peptidase-IV

Thiadiazoles

Heterobicyclic Compounds

Bicyclic Aryl

CXC Ligands

Heterotricyclic

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10166250 - Bicyclic aryl sphingosine 1-phosphate analogs (2019-01-01),

2. 10081646 - Heterobicyclic sphingosine 1-phosphate analogs (2018-09-25),

3. 10017506 - ATX modulating agents (2018-07-10),

4. 9944666 - Compounds that are S1P modulating agents and/or ATX modulating agents (2018-04-17),

5. 9850206 - S1P and/or ATX modulating agents (2017-12-26),

6. 9827258 - Bicyclic aryl sphingosine 1-phosphate analogs (2017-11-28),

7. 9771326 - S1P and/or ATX modulating agents (2017-09-26),

8. 9708353 - Heterobicyclic sphingosine 1-phosphate analogs (2017-07-18),

9. 9572824 - Bicyclic aryl sphingosine 1-phosphate analogs (2017-02-21),

10. 9555050 - ATX modulating agents (2017-01-31),

11. 9550798 - Compounds that are S1P modulating agents and/or ATX modulating agents (2017-01-24),

12. 9522889 - ATX modulating agents (2016-12-20),

13. 9186367 - Bicyclic aryl sphingosine 1-phosphate analogs (2015-11-17),

14. 9181191 - Heterobicyclic sphingosine 1-phosphate analogs (2015-11-10),

15. 8835441 - Heterobicyclic metalloprotease inhibitors (2014-09-16),

Title: The Innovative Journey of Arthur G Taveras

Introduction: Arthur G Taveras is a renowned inventor based in Southborough, MA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Arthur G Taveras holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Arthur G Taveras has worked with leading companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Arthur G Taveras has collaborated with top researchers, engineers, and designers to bring his innovative ideas to life, resulting in successful products and technologies.

Conclusion: Arthur G Taveras continues to inspire with his inventive spirit and dedication to creating solutions that make a difference in the world.

Profile summary based on public USPTO records.